Patents by Inventor Michael E. Lewis

Michael E. Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040102157
    Abstract: A directional antenna system is disclosed in which a plurality of RF nodes are provided for cooperatively forming a directional antenna array for transmitting and receiving wireless signals between a wireless client at a predetermined position in space. One or more network interface assemblies are provided for exchanging signals between the plurality of RF nodes and a network. Preferably, the plurality of RF nodes are distributed in space with respect to each other and the network interface assembly The network interface includes a beamformer for applying a plurality of antenna weighting factors to the respective RF nodes, for introducing phase differences in the respective transmitted and received wireless signals that produce a directional steering vector for the wireless signals.
    Type: Application
    Filed: November 27, 2002
    Publication date: May 27, 2004
    Inventor: Michael E. Lewis
  • Patent number: 6723699
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: April 22, 1998
    Date of Patent: April 20, 2004
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, Kathleen V. Callison, Frank Baldino
  • Patent number: 6693076
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: February 17, 2004
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino
  • Publication number: 20020088720
    Abstract: An apparatus for prevention of corrosion in metal objects uses a capacitively coupled fastener or pad attached to a metal body being protected from corrosion. The metal body and the negative terminal of a source of DC voltage (battery) are grounded. The positive terminal of the source of DC voltage is connected to electronic circuitry that imparts pulses of low voltage DC through the capacitor to the fastener. These pulses of electrical current inhibit the oxidation of the metal object by providing a source of electrons to the oxidizing chemicals in contact with the metal. The electronic circuitry includes a reverse voltage protector to prevent the application of reverse source voltage. The circuitry also includes a power conditioner to supply a constant DC voltage to a microprocessor. The microprocessor generates pulses of DC signals that are amplified by a pulse amplifier and imparted to the conductive facing of the pad. For larger objects, a first and second cable are attached to a metal object.
    Type: Application
    Filed: December 7, 2001
    Publication date: July 11, 2002
    Applicant: Red Swan, Inc.
    Inventors: Michael E. Lewis, Mark Swannie
  • Patent number: 6331243
    Abstract: An apparatus for prevention of corrosion in metal objects uses a capacitively coupled fastener or pad attached to a metal body being protected from corrosion. The metal body and the negative terminal of a source of DC voltage (battery) are grounded. The positive terminal of the source of DC voltage is connected to electronic circuitry that imparts pulses of low voltage DC through the capacitor to the fastener. These pulses of electrical current inhibit the oxidation of the metal object by providing a source of electrons to the oxidizing chemicals in contact with the metal. The electronic circuitry includes a reverse voltage protector to prevent the application of reverse source voltage. The circuitry also includes a power conditioner to supply a constant DC voltage to a microprocessor. The microprocessor generates pulses of DC signals that are amplified by a pulse amplifier and imparted to the conductive facing of the pad. The invention also includes a battery voltage monitor and a power indicator.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: December 18, 2001
    Assignee: Red Swan, Inc.
    Inventor: Michael E. Lewis
  • Patent number: 6310040
    Abstract: Disclosed is a method for promoting retinal neuronal survival in a mammal, wherein the neuronal cells are at risk of dying. The method comprises administering to the mammal an effective dose of at least one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; or a functional derivative of IGF-II.
    Type: Grant
    Filed: October 15, 1992
    Date of Patent: October 30, 2001
    Assignee: Cephalon, Inc.
    Inventors: Donna Bozyczko-Coyne, Nicola Neff, Michael E. Lewis, Mohamed A. Iqbal
  • Patent number: 6046515
    Abstract: An apparatus for prevention of corrosion in metal objects uses a pad having a conductive facing, a dielectric substrate and an adhesive, attached to a metal body being protected from corrosion. The metal body and the negative terminal of a source of DC voltage (battery) are grounded. The positive terminal of the source of DC voltage is connected to electronic circuitry that imparts pulses of low voltage DC to the conductive facing of the pad. These pulses of electrical current inhibit the oxidation of the metal object by providing a source of electrons to the oxidizing chemicals in contact with the metal. The electronic circuitry includes a reverse voltage protector to prevent the application of reverse source voltage. The circuitry also includes a power conditioner to supply a constant DC voltage to a microprocessor. The microprocessor generates pulses of DC signals that are amplified by a pulse amplifier and imparted to the conductive facing of the pad.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: April 4, 2000
    Inventor: Michael E. Lewis
  • Patent number: 5776897
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: July 7, 1998
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino, Nicola Neff, Mohamed Iqbal
  • Patent number: 5756494
    Abstract: The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: May 26, 1998
    Assignees: Cephalon, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata, Hiromitsu Saito, Yuzuru Matsuda, Marcie A. Glicksman, Fumihiko Kanai, Masami Kaneko
  • Patent number: 5741808
    Abstract: The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
    Type: Grant
    Filed: February 14, 1997
    Date of Patent: April 21, 1998
    Assignees: Cephalon, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata, Hiromitsu Saito, Yuzuru Matsuda, Marcie A. Glicksman, Fumihiko Kanai, Masami Kaneko
  • Patent number: 5703045
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of at least one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 30, 1997
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino, Nicola Neff, Mohamed Iqbal
  • Patent number: 5652214
    Abstract: A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method including the step of administering to the mammal one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
    Type: Grant
    Filed: October 7, 1992
    Date of Patent: July 29, 1997
    Assignee: Cephalon, Inc.
    Inventors: Michael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino, Nicola Neff, Mohamed Iqbal
  • Patent number: 5648335
    Abstract: The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: July 15, 1997
    Assignees: Cephalon, Inc., Albert Einstein College of Medicine of Yeshiva Univ.
    Inventors: Michael E. Lewis, Stuart C. Apfel, John A. Kessler
  • Patent number: 5633228
    Abstract: The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
    Type: Grant
    Filed: December 29, 1994
    Date of Patent: May 27, 1997
    Assignees: Cephalon, Inc.,, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Michael E. Lewis, Stuart C. Apfel, John A. Kessler
  • Patent number: 5621100
    Abstract: The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
    Type: Grant
    Filed: October 26, 1994
    Date of Patent: April 15, 1997
    Assignees: Cephalon, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata, Hiromitsu Saito, Yuzuru Matsuda, Marcie A. Glicksman, Fumihiko Kanai, Masami Kaneko
  • Patent number: 5621101
    Abstract: The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 15, 1997
    Assignees: Cephalon, Inc., Kyowa Hakko Kogyo
    Inventors: Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata, Hiromitsu Saito, Yuzuru Matsuda, Marcie A. Glicksman, Fumihiko Kanai, Masami Kaneko
  • Patent number: 5577933
    Abstract: A watthour meter mounting apparatus, such as a socket, socket adapter and the like, has a safety shield completely enclosing the jaw contacts of the apparatus. Slots are formed in the safety shield to allow the insertion of a watthour meter blade terminal therethrough into connection with the jaw contacts. In one embodiment, a socket adapter housing includes front and back plates which are joined together and form a cavity therebetween in which the jaw terminals and the electrical conductors are disposed. Raised receptacles formed in the first plate loosely receive the jaw contacts mounted on one end of the conductors. In another embodiment, an insulating housing is mounted over the jaw contacts in a socket or socket adapter, with slots formed in the housing to allow the insertion of a watthour meter blade terminal therethrough into a jaw contact disposed within the housing.
    Type: Grant
    Filed: August 30, 1995
    Date of Patent: November 26, 1996
    Assignee: Ekstrom Industries, Inc.
    Inventors: Darrell Robinson, Robert O. Learmont, Karl R. Loehr, Robert Goozen, Michael E. Lewis, Allen V. Pruehs
  • Patent number: 5571031
    Abstract: A watthour meter mounting apparatus, such as a socket, socket adapter and the like, has a flash shield completely enclosing the jaw contacts of the apparatus. Slots are formed in the flash shield to allow the insertion of a watthour meter blade terminal therethrough into connection with the jaw contacts. In one embodiment, a socket adapter housing includes front and back plates which are joined together and form a cavity therebetween in which the jaw terminals and the electrical conductors are disposed. Raised receptacles formed in the first plate loosely receive the jaw contacts mounted on one end of the conductors. In another embodiment, an insulating housing is mounted over the jaw contacts in a socket or socket adapter, with slots formed in the housing to allow the insertion of a watthour meter blade terminal therethrough into a jaw contact disposed within the housing.
    Type: Grant
    Filed: August 30, 1995
    Date of Patent: November 5, 1996
    Assignee: Ekstrom Industries, Inc.
    Inventors: Darrell Robinson, Robert O. Learmont, Karl R. Loehr, Robert Goozen, Michael E. Lewis, Allen V. Pruehs
  • Patent number: 5569648
    Abstract: The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
    Type: Grant
    Filed: December 29, 1994
    Date of Patent: October 29, 1996
    Assignees: Cephalon, Inc., Albert Einstein College of Medicine of Yeshiva University
    Inventors: Michael E. Lewis, Stuart C. Apfel, John A. Kessler
  • Patent number: 5461146
    Abstract: The invention features novel derivatives of K-252a, as well as novel bis-N-substituted derivatives of staurosporine. Also, a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a.
    Type: Grant
    Filed: July 22, 1993
    Date of Patent: October 24, 1995
    Assignees: Cephalon, Inc., Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Michael E. Lewis, James C. Kauer, Nicola Neff, Jill Roberts-Lewis, Chikara Murakata, Hiromitsu Saito, Yuzuru Matsuda, Marcie A. Glicksman